As reported on Pharmaceutical Business Review, Affinia Therapeutics has been granted orphan drug designation by the US Food and Drug Administration (FDA) for AFTX-201, an
As reported on Fierce BioTech, Johnson & Johnson has received U.S. Food and Drug Administration (FDA) clearance for its Ottava Robotic Surgical System, marking a
As reported on Science Daily, scientists have combined polymer-coated nanoparticles with therapeutic drugs for cancer treatment, including treatment for ovarian cancer. The nanoparticles target tumors
As reported by The Manila Times, Abeona Therapeutics has announced that Cincinnati Children’s Hospital Medical Center has been designated as the seventh Qualified Treatment Center
Medical device innovator Xeltis has officially kicked off the European commercial rollout of its novel vascular access implant, aXess™. The milestone was marked by the
The FDA has Completed Its Investigation of the Recent 2024 Deaths of Two Young Boys Due to Liver Failure. Acute failure of the liver has
The pharmaceutical company Grifols—has started dosing patients in the final stage (Phase 3) of two clinical trials. The company is trying to get approval to
Editor’s Note: This article was shared with us by our friends at the AAMDS International Foundation. To see the article in its original format, please
A newly reported case from Nanchang University suggests that efgartigimod, a neonatal Fc receptor (FcRn) blocker approved for generalized myasthenia gravis, may offer a promising
Merck has reported positive topline findings from the Phase 3 KEYNOTE-C93 trial, demonstrating that pembrolizumab (KEYTRUDA®) significantly extended progression-free survival (PFS) compared with standard platinum-based
If you or a loved one has ever survived a stroke, you know that the hardest part of the journey often begins after you leave
Editor’s Note: This article was originally written and submitted to us by Regina Portnoy. When people think about leadership in clinical research, they often think
Editor’s Note: This is part 2 of a 3-part caregiver story, submitted to us by Joan Foster, who was a caregiver for her husband Charles’
As reported on Inside Precision Medicine, for years, a chronic spinal cord injury (SCI) has felt like a permanent biological roadblock. When the spinal cord
Thoughts occur in the mind, when the electrical circuits in the brain through neurons and synapses and chemicals all function together. Processes of the mind
As reported on Fierce Pharma, Huyabio has reported encouraging Phase 3 results for its investigational oral HDAC inhibitor, HBI-8000, when used alongside Bristol Myers Squibb’s
I was diagnosed with myasthenia gravis, or MG, in 2021 when I was in my early 20s. My journey began at a friend’s birthday party
Editor’s Note: This is part 2 of a 3-part caregiver story, submitted to us by Joan Foster, who was a caregiver for her husband Charles’
Some changes happen so gradually that you don't notice them until you stop and look back.
The path after a diagnosis is rarely the one anyone would choose, but it often brings unexpected lessons, perspectives, and growth along the way. Even on the hardest days, there may be moments that remind you just how far you've come.
#chronicillness #raredisease #invisibleillness #youarenotalone #PatientWorthy
🌍#23luglio Giornata mondiale della malattia di #Castleman: al via la campagna internazionale di sensibilizzazione. Il Castleman Disease Collaborative Network (#CDCN):
💙invita i pazienti a condividere le loro storie
💙sostiene l’adesione al Registro di malattia
💙promuove la donazione di campioni biologici
💙chiede di indossare qualcosa di blu
🇮🇹 In Italia AMICa - Associazione Malati Italiani Castleman è al fianco di pazienti e famiglie dal 2021
Leggi la news
▶️https://tinyurl.com/mrx9dys9
#WorldCastlemanDiseaseDay #WorldCDDay
@follower
@CastlemanDiseaseCollaborativeNetwork
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
